• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管癌的术前分期:计算机断层扫描能否可靠地识别Ⅲ期肿瘤?

Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours?

作者信息

White P G, Adams H, Crane M D, Butchart E G

机构信息

Department of Radiology, Llandough Hospital, NHS Trust, Penarth, South Glamorgan, UK.

出版信息

Thorax. 1994 Oct;49(10):951-7. doi: 10.1136/thx.49.10.951.

DOI:10.1136/thx.49.10.951
PMID:7974310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC475227/
Abstract

BACKGROUND

The aim of preoperative computed tomographic (CT) assessment of patients with carcinoma of the bronchus is to stage the tumour accurately, and forewarn the surgeon of any possible local extrapulmonary extension of tumour in patients considered to have potentially resectable disease. The ability of CT scanning to differentiate between conventionally resectable lung cancer (TNM stages I and II), locally advanced but resectable lung cancer (TNM stage IIIa), and locally advanced but unresectable lung cancer (TNM stage IIIb) was determined in a group of patients accepted for surgery.

METHODS

Computed tomographic scans of 110 patients who underwent thoracotomy for intended resection of carcinoma of the bronchus, including 52 cases with stage III and 58 cases with stage I or II disease, were reviewed and the CT features and radiological interpretations correlated with the surgical and pathological findings.

RESULTS

Thirteen CT scans were judged not to have been of diagnostic quality: of the remaining 97 cases 45 had stage III lung cancer, of whom 30 had successful resections, and 52 had stage I or stage II tumours. There was no difference in the frequencies of CT observations--including contiguity of tumour and mediastinum or chest wall, apparent mediastinal or chest wall invasion, proximity of tumour to the carina, mediastinal nodal enlargement, pulmonary collapse or consolidation and pleural effusion--in patients with stage I/II disease and patients with stage III disease. Similar results were found when the same observations were compared in all patients with resected disease and those with unresectable tumour. Sensitivity and specificity of CT was 27% and 96% respectively for tumour unresectability, 50% and 89% for mediastinal invasion, 14% and 99% for chest wall invasion, and 61% and 76% for mediastinal nodal metastases. Only 19 of 45 stage III tumours were correctly identified as being stage III and resectable or unresectable.

CONCLUSIONS

In patients being considered for thoracotomy for resection of lung cancer, CT scanning used as the sole method of staging is of limited value for differentiating between stage I/II and stage III tumours. Patients should not be denied the opportunity for curative surgery on the basis of equivocal CT signs.

摘要

背景

对支气管癌患者进行术前计算机断层扫描(CT)评估的目的是准确对肿瘤进行分期,并在认为可能可切除的患者中,预先警告外科医生肿瘤任何可能的肺外局部扩展情况。在一组接受手术的患者中,确定了CT扫描区分传统可切除肺癌(TNM分期I期和II期)、局部晚期但可切除肺癌(TNM分期IIIA期)以及局部晚期但不可切除肺癌(TNM分期IIIB期)的能力。

方法

回顾了110例因计划切除支气管癌而接受开胸手术患者的CT扫描结果,其中包括52例III期患者和58例I期或II期患者,并将CT特征及影像学解释与手术和病理结果进行关联。

结果

13份CT扫描被判定诊断质量不佳:在其余97例病例中,45例为III期肺癌,其中30例成功切除,52例为I期或II期肿瘤。I/II期疾病患者和III期疾病患者在CT观察结果(包括肿瘤与纵隔或胸壁的连续性、明显的纵隔或胸壁侵犯、肿瘤与隆突的距离、纵隔淋巴结肿大、肺不张或实变以及胸腔积液)的频率上没有差异。在所有可切除疾病患者和不可切除肿瘤患者中比较相同观察结果时,也发现了类似结果。对于肿瘤不可切除,CT的敏感性和特异性分别为27%和96%;对于纵隔侵犯,分别为50%和89%;对于胸壁侵犯,分别为14%和99%;对于纵隔淋巴结转移,则分别为61%和76%。45例III期肿瘤中只有19例被正确判定为III期且可切除或不可切除。

结论

在考虑行开胸手术切除的患者中,仅将CT扫描用作分期方法在区分I/II期和III期肿瘤方面价值有限。不应基于不明确的CT征象而剥夺患者进行根治性手术的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e0/475227/83186f34bd4e/thorax00302-0021-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e0/475227/6fe94f616d4c/thorax00302-0020-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e0/475227/e2ba3d6382ad/thorax00302-0020-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e0/475227/99b3c49167e0/thorax00302-0021-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e0/475227/83186f34bd4e/thorax00302-0021-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e0/475227/6fe94f616d4c/thorax00302-0020-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e0/475227/e2ba3d6382ad/thorax00302-0020-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e0/475227/99b3c49167e0/thorax00302-0021-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e0/475227/83186f34bd4e/thorax00302-0021-b.jpg

相似文献

1
Preoperative staging of carcinoma of the bronchus: can computed tomographic scanning reliably identify stage III tumours?支气管癌的术前分期:计算机断层扫描能否可靠地识别Ⅲ期肿瘤?
Thorax. 1994 Oct;49(10):951-7. doi: 10.1136/thx.49.10.951.
2
Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions.支气管源性癌:CT在疑似病变患者评估中的应用
Radiology. 1994 Dec;193(3):795-800. doi: 10.1148/radiology.193.3.7972827.
3
Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma.支气管源性癌分期中影像学TNM [(i)TNM]与病理TNM [pTNM]的比较。
Eur J Cardiothorac Surg. 1997 Aug;12(2):224-7. doi: 10.1016/s1010-7940(97)00084-5.
4
[Multimodal treatment of non small cell lung cancer].[非小细胞肺癌的多模式治疗]
Zentralbl Chir. 2006 Apr;131(2):110-4. doi: 10.1055/s-2006-921534.
5
Preoperative staging of lung cancer: accuracy of computed tomography versus mediastinoscopy.肺癌的术前分期:计算机断层扫描与纵隔镜检查的准确性
Thorax. 1983 Jan;38(1):10-5. doi: 10.1136/thx.38.1.10.
6
Lung cancer staging: the role of computed tomography and magnetic resonance imaging.肺癌分期:计算机断层扫描和磁共振成像的作用
Eur J Radiol. 1996 Aug;23(1):35-45. doi: 10.1016/0720-048x(96)01032-7.
7
Resectable stage III lung cancer: CT, surgical, and pathologic correlation.可切除的Ⅲ期肺癌:CT、手术及病理相关性
Radiology. 1988 Jan;166(1 Pt 1):75-9. doi: 10.1148/radiology.166.1.3336705.
8
Computed tomography and the TNM classification of lung cancer.计算机断层扫描与肺癌的TNM分期
Scand J Thorac Cardiovasc Surg. 1990;24(3):207-11. doi: 10.3109/14017439009098071.
9
Assessing non-resectability of lung cancer. The value of thoracic computed tomography.评估肺癌的不可切除性。胸部计算机断层扫描的价值。
Rofo. 1991 Sep;155(3):218-22. doi: 10.1055/s-2008-1033250.
10
[Resectable bronchial cancer. Contribution of computed x-ray tomography in the evaluation of loco-regional extension].[可切除支气管癌。计算机断层扫描在评估局部区域扩展中的作用]
J Radiol. 1986 Oct;67(10):675-9.

引用本文的文献

1
SEOM-SERAM-SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer.SEOM-SERAM-SEMNIM 指南:在晚期非小细胞肺癌中使用功能和分子成像技术。
Clin Transl Oncol. 2018 Jul;20(7):837-852. doi: 10.1007/s12094-017-1795-y. Epub 2017 Dec 18.
2
Evaluation of lymph node metastasis in lung cancer: who is the chief justice?肺癌中淋巴结转移的评估:谁是“首席法官”?
J Thorac Dis. 2015 Dec;7(Suppl 4):S231-7. doi: 10.3978/j.issn.2072-1439.2015.11.63.
3
Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging.

本文引用的文献

1
Staging non-small cell lung cancer.非小细胞肺癌的分期
Clin Radiol. 1993 Jul;48(1):1-10. doi: 10.1016/s0009-9260(05)80099-6.
2
The value of adjuvant radiotherapy in pulmonary and chest wall resection for bronchogenic carcinoma.辅助放疗在支气管源性肺癌肺及胸壁切除术中的价值。
Ann Thorac Surg. 1982 Dec;34(6):692-7. doi: 10.1016/s0003-4975(10)60911-3.
3
Bronchogenic carcinoma with chest wall invasion: factors affecting survival following en bloc resection.伴有胸壁侵犯的支气管源性癌:整块切除术后影响生存的因素。
计算断层扫描和磁共振成像在提高肺结节检测和肺癌分期方面的最新技术和应用进展。
J Magn Reson Imaging. 2010 Dec;32(6):1353-69. doi: 10.1002/jmri.22383.
4
[Endobronchial ultrasound].[支气管内超声]
Radiologe. 2010 Aug;50(8):692-8. doi: 10.1007/s00117-009-1946-4.
5
The clinical feasibility of using non-breath-hold real-time MR-echo imaging for the evaluation of mediastinal and chest wall tumor invasion.使用非屏气实时磁共振回波成像评估纵隔和胸壁肿瘤侵犯的临床可行性。
Korean J Radiol. 2010 Jan-Feb;11(1):37-45. doi: 10.3348/kjr.2010.11.1.37. Epub 2009 Dec 28.
6
[Solitary pulmonary nodule. Assessment and therapy].[孤立性肺结节。评估与治疗]
Chirurg. 2007 Aug;78(8):687-97. doi: 10.1007/s00104-007-1379-4.
7
Subtle pleural metastasis without large effusion in lung cancer patients: preoperative detection on CT.肺癌患者无大量胸腔积液的细微胸膜转移:CT术前检测
Korean J Radiol. 2005 Apr-Jun;6(2):94-101. doi: 10.3348/kjr.2005.6.2.94.
8
Requirements for clinical PET: comparisons within Europe.临床正电子发射断层显像(PET)的要求:欧洲范围内的比较
Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):208-21. doi: 10.1007/s00259-003-1351-6.
9
Effectiveness of positron emission tomography for the detection of melanoma metastases.正电子发射断层扫描在检测黑色素瘤转移灶方面的有效性。
Ann Surg. 1998 May;227(5):764-9; discussion 769-71. doi: 10.1097/00000658-199805000-00017.
10
Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).非小细胞肺癌的淋巴结分期:通过[18F]氟代脱氧葡萄糖正电子发射断层扫描(PET)进行评估。
Thorax. 1997 May;52(5):438-41. doi: 10.1136/thx.52.5.438.
Ann Thorac Surg. 1982 Dec;34(6):684-91. doi: 10.1016/s0003-4975(10)60909-5.
4
The mediastinum in non-small cell lung cancer: CT-surgical correlation.非小细胞肺癌中的纵隔:CT与手术的相关性
AJR Am J Roentgenol. 1984 Jun;142(6):1101-5. doi: 10.2214/ajr.142.6.1101.
5
Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation.支气管肺癌的胸膜及胸壁侵犯:CT评估
Radiology. 1985 Oct;157(1):191-4. doi: 10.1148/radiology.157.1.4034965.
6
Chest wall invasion by lung cancer: limitations of CT evaluation.肺癌侵犯胸壁:CT评估的局限性
AJR Am J Roentgenol. 1985 Mar;144(3):507-11. doi: 10.2214/ajr.144.3.507.
7
Limitations of CT in evaluation of neoplasms involving chest wall.CT在评估累及胸壁的肿瘤方面的局限性。
J Comput Assist Tomogr. 1987 Mar-Apr;11(2):290-3. doi: 10.1097/00004728-198703000-00019.
8
Computed tomography for the evaluation of intrathoracic invasion by lung cancer.用于评估肺癌胸内侵犯的计算机断层扫描
J Thorac Cardiovasc Surg. 1987 Jul;94(1):57-63.
9
Resectable stage III lung cancer: CT, surgical, and pathologic correlation.可切除的Ⅲ期肺癌:CT、手术及病理相关性
Radiology. 1988 Jan;166(1 Pt 1):75-9. doi: 10.1148/radiology.166.1.3336705.
10
Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation.支气管源性癌纵隔侵犯不明确的CT评估
Radiology. 1989 Oct;173(1):37-42. doi: 10.1148/radiology.173.1.2781028.